Results 171 to 180 of about 1,202,565 (290)

Prognostic Models Using the Lactate-to-Albumin Ratio for 28-Day Mortality in ICU Sepsis Patients: A Bayesian Model Averaging Approach. [PDF]

Int J Gen Med
Hoang QV, Le NTK, Hoang LV, Vu DA, Ho DS.   +4 more
europepmc   +1 more source

Robust Bayesian meta-analysis: Model-averaging across complementary publication bias adjustment methods. [PDF]

Res Synth Methods, 2023
Bartoš F, Maier M, Wagenmakers EJ, Doucouliagos H, Stanley TD.   +4 more
europepmc   +1 more source

RaMBat: Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects

Molecular Oncology, EarlyView.
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley   +1 more source

Dynamic Prediction of an Event Using Multiple Longitudinal Markers: A Model Averaging Approach. [PDF]

Stat Med
Hashemi R, Baghfalaki T, Philipps V, Jacqmin-Gadda H.   +3 more
europepmc   +1 more source

Frequentist Model Averaging in Structure Equation Model With Ordinal Data. [PDF]

Psychometrika, 2022
Jin S.
europepmc   +1 more source

Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver

Molecular Oncology, EarlyView.
Meta‐transcriptome analysis identified FGF19 as a peptide enteroendocrine hormone associated with colorectal cancer prognosis. In vivo xenograft models showed release of FGF19 into the blood at levels that correlated with tumor volumes. Tumoral‐FGF19 altered murine liver metabolism through FGFR4, thereby reducing bile acid synthesis and increasing ...
Jordan M. Beardsley, Michael W. Rohr, Joseph A. Goode, Sai Preethi Nakkina, Jignesh G. Parikh, Deborah A. Altomare   +5 more
wiley   +1 more source

Overcoming Model Uncertainty - How Equivalence Tests Can Benefit From Model Averaging. [PDF]

Stat Med
Hagemann N, Möllenhoff K.
europepmc   +1 more source

Continuous Model Averaging for Benchmark Dose Analysis: Averaging Over Distributional Forms. [PDF]

Environmetrics, 2022
Wheeler MW, Cortinas J, Aerts M, Gift JS, Davis JA.   +4 more
europepmc   +1 more source

Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma

Molecular Oncology, EarlyView.
Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra, Lucca Paolo Hsu Helmich, Daniel Rodrigues de Bastos, Laura Sichero, Patrícia Savio de Araujo‐Souza, Fabio Passetti, Luisa Lina Villa   +6 more
wiley   +1 more source

Within-project and cross-project defect prediction based on model averaging. [PDF]

Sci Rep
Li T, Wang Z, Shi P.
europepmc   +1 more source